These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 25861355)

  • 1. Alternative antimicrobial approach: nano-antimicrobial materials.
    Beyth N; Houri-Haddad Y; Domb A; Khan W; Hazan R
    Evid Based Complement Alternat Med; 2015; 2015():246012. PubMed ID: 25861355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
    Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
    mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomaterials: The New Antimicrobial Magic Bullet.
    Ndayishimiye J; Kumeria T; Popat A; Falconer JR; Blaskovich MAT
    ACS Infect Dis; 2022 Apr; 8(4):693-712. PubMed ID: 35343231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterials for alternative antibacterial therapy.
    Hemeg HA
    Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials.
    Bassegoda A; Ivanova K; Ramon E; Tzanov T
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2075-2089. PubMed ID: 29392390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticles as antimicrobial agents: their toxicity and mechanisms of action.
    Herman A; Herman AP
    J Nanosci Nanotechnol; 2014 Jan; 14(1):946-57. PubMed ID: 24730311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
    Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
    J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
    Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
    Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalization of Inorganic Nanoparticles to Augment Antimicrobial Efficiency: A Critical Analysis.
    Khan K; Javed S
    Curr Pharm Biotechnol; 2018; 19(7):523-536. PubMed ID: 30062962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
    Shaaban MI; Shaker MA; Mady FM
    J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dealing with MDR bacteria and biofilm in the post-antibiotic era: Application of antimicrobial peptides-based nano-formulation.
    Song X; Liu P; Liu X; Wang Y; Wei H; Zhang J; Yu L; Yan X; He Z
    Mater Sci Eng C Mater Biol Appl; 2021 Sep; 128():112318. PubMed ID: 34474869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured Antibiotics and Their Emerging Medicinal Applications: An Overview of Nanoantibiotics.
    Modi S; Inwati GK; Gacem A; Saquib Abullais S; Prajapati R; Yadav VK; Syed R; Alqahtani MS; Yadav KK; Islam S; Ahn Y; Jeon BH
    Antibiotics (Basel); 2022 May; 11(6):. PubMed ID: 35740115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Palau M; Muñoz E; Gusta MF; Larrosa N; Gomis X; Gilabert J; Almirante B; Puntes V; Texidó R; Gavaldà J
    Microbiol Spectr; 2023 Jun; 11(3):e0028023. PubMed ID: 37078875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial applications of nanotechnology: methods and literature.
    Seil JT; Webster TJ
    Int J Nanomedicine; 2012; 7():2767-81. PubMed ID: 22745541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans".
    Baptista PV; McCusker MP; Carvalho A; Ferreira DA; Mohan NM; Martins M; Fernandes AR
    Front Microbiol; 2018; 9():1441. PubMed ID: 30013539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of methods to detect the in vitro activity of silver nanoparticles (AgNP) against multidrug resistant bacteria.
    Cavassin ED; de Figueiredo LF; Otoch JP; Seckler MM; de Oliveira RA; Franco FF; Marangoni VS; Zucolotto V; Levin AS; Costa SF
    J Nanobiotechnology; 2015 Oct; 13():64. PubMed ID: 26438142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Yang C; Lou W; Zhong G; Lee A; Leong J; Chin W; Ding B; Bao C; Tan JPK; Pu Q; Gao S; Xu L; Hsu LY; Wu M; Hedrick JL; Fan W; Yang YY
    Acta Biomater; 2019 Aug; 94():268-280. PubMed ID: 31129359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hope for ineffective antibiotics to return to treatment: investigating the anti-biofilm potential of melittin alone and in combination with penicillin and oxacillin against multidrug resistant-MRSA and -VRSA.
    Jalalifar S; Razavi S; Mirzaei R; Irajian G; Pooshang Bagheri K
    Front Microbiol; 2023; 14():1269392. PubMed ID: 38370578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.